Hi ,
The way I see it if we dont get a successful trial result with Covid we most likely dont really have a product that is ever going to be approved.
The ARDS trial falls right in Rememstemcel L sweet spot according to Mesoblast so combined with various other successful documented trials using MSC Iam seeing and hoping for a positive result.
Aloha.
- Forums
- ASX - By Stock
- MSB
- Ann: Phase 3 Trial in COVID-19 ARDS Surpasses 50% Enrollment
Ann: Phase 3 Trial in COVID-19 ARDS Surpasses 50% Enrollment, page-361
-
- There are more pages in this discussion • 85 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.19 |
Change
0.000(0.00%) |
Mkt cap ! $1.358B |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1600 | $1.25 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.16 | 7526 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1600 | 1.250 |
1 | 8771 | 1.245 |
2 | 2600 | 1.220 |
3 | 150 | 1.210 |
1 | 500 | 1.205 |
Price($) | Vol. | No. |
---|---|---|
1.125 | 5536 | 2 |
1.140 | 38575 | 6 |
1.150 | 50126 | 2 |
1.160 | 727 | 2 |
1.165 | 65 | 1 |
Last trade - 09.42am 15/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
Day chart unavailable